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Abstract  
AIM: To study the interaction between sleep deprivation, obesity and cognitive functions, and the 
effect of following a balanced low caloric diet and increasing sleep duration on those variables.  
SUBJECTS AND METHODS: Ninety two obese females with mean age 47.00 ± 2.00 years and 
body mass index (BMI) 36.14 ± 3.00 kg/m² were divided into 3 groups according to their sleeping 
hours. They followed balanced low-caloric diet and were instructed to increase sleeping hours. Full 
clinical examination, 24 hours dietary intake recall, anthropometric measurements, mini mental 
state test, questionnaire for subjective sleep and life style evaluation were performed at baseline 
and after 2 months. Serum visfatin, fasting blood glucose and C-peptide were assessed; Modified 
homeostatic model assessment of insulin resistance was calculated.  
RESULTS: About one third of our sample slept less than 6 hours daily, group (1), all patients had 
elevated visfatin serum level (33.87 ± 2.8 ng/ml) with the highest level in group (1). At base line, 
group (1) showed the highest BMI, lowest cognitive functions, highest visfatin level and highest 
insulin resistance (P < 0.05). After 2 months of intervention, improvement was recorded in all 
variables, with the best improvement in group (1) after extending sleep duration (P < 0.05). 
CONCLUSION: Sleep deprivation may be a modifiable risk factor for obesity, cognitive impairment 
and visfatin elevation. 
 
 
 
 
 
Introduction 
 
Obesity is a leading cause of morbidity and 
mortality in the 21
st
 century and its prevalence has 
been rapidly increasing over the past 30 years. 
Recently, a similar growth in self-reported sleep 
deprivation has been noticed, paralleling the obesity 
epidemic. It is estimated that average sleep time has 
fallen in the general population by an average of 2 
hours per night [1, 2]. Chronic sleep deprivation and 
obesity may be two linked phenomena with similar 
epidemiology [3]. Chronic sleep deprivation has been 
associated with many chronic conditions. This 
includes increased body weight, glucose intolerance, 
cardiovascular disease, hypertension, cognitive 
impairment and impaired immune system function. 
Several epidemiological studies have shown that 
people who report sleeping less than 6.5 hours are at 
greater risk of gaining weight over time. Sleep may be 
an important regulator of energy metabolism in 
peripheral tissues [4, 5]. On the other hand, excessive 
sleep duration also has been associated with 
increased morbidity, suggesting a U-shaped curve 
between sleep duration and morbidity/mortality [6].  
  Sleep and the internal circadian clock 
influence a host of endocrine parameters, which alters 
multiple metabolic pathways, leading to insulin 
resistance, possibly decreased energy expenditure, 
increased appetite, and immunological changes [7]. It 
was reported that sleep deprivation predominantly 
interferes with attention and memory [8]. In turn, this 
was proved to affect cognitive function and increase 
the risk of Alzheimer. An interesting study reported 
that Low levels in the cerebrospinal fluid of β amyloid 
42 (Aβ 42), which signifies the presence of amyloid 
plaques, are associated with poor sleep efficiency [9]. 
Poor sleep puts people at a greater risk for cognitive 
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impairment. A study reported that getting even 1 hour 
less than the required sleep (7 to 8 hour nightly) leads 
to problems with memory, concentration and attention 
[10]. Furthermore, sleep extension can improve 
neurocognitive functions in chronically sleep deprived 
obese individuals [11]. Interestingly, six days of partial 
sleep restriction increased the activation of food 
reward pathways –a putative pathway leading to 
weight gain [12]. 
Low-grade systemic inflammation due 
to obesity is considered to be the key link 
between obesity and obesity-related disorders which 
include cognitive impairment [1]. Nicotinamide 
phosphoribosyltransferase (Visfatin) is an 
adipocytokine produced primarily by visceral adipose 
tissue. Visfatin exerts insulin-mimetic effects via 
binding and activating the insulin receptor. In addition 
to its effect on the insulin receptor, it is a 
proinflammmatory cytokine with accumulating 
evidence for its rise in circulation, accompanying 
systemic inflammation [13]. Higher levels 
of visfatin were reported among obese in several 
studies. It has been proposed as playing a role in the 
pathogenesis of insulin resistance which is one of the 
causes of cognitive impairment. This was 
accompanied with higher levels of homeostatic model 
assessment of insulin resistance (HOMA-IR). In 
addition, several studies reported that short sleep time 
was predictive of higher Visfatin levels [14, 15].  
The aim of this study was to test the effect of 
increasing sleeping hours and improving sleep quality 
on obesity and cognitive functions, as well as to 
examine serum visfatin in relation to the other 
variables under study, and to test the possibility of 
being used as a biochemical marker. 
 
 
Subjects and Methods  
 
Subjects 
  Ninety two obese females were included in 
this study with mean age of 47.00 ± 2.00 years and 
body mass index (BMI) of 36.14 ± 3.00 kg/m². They 
were all enrolled in a program for losing weight at the 
Nutrition Department, National Research Centre. 
 
Intervention lasted for 2 months 
1 - All the participants were put on a balanced 
low-caloric diet (1000- 1200 K calories/ day). 
2 - After the first visit evaluation, the 
participants were divided into 3 main groups 
according to their sleeping hours per night, those who 
slept from 4-6 hours per night were instructed to make 
some changes in their life style in order to increase 
sleeping hours by 1-2 hours per night.  
The participants were informed about the 
purpose of the study and their permission in the form 
of written consent was obtained. The protocol was 
approved by the "Ethical Committee" of the "National 
Research Centre". 
 
Methods 
All subjects were examined at baseline and 
after two months of following the balanced low-caloric 
diet (1000- 1200 K calories/ day). 
1 - Full clinical examination. 
2 - Mini Mental State Examination (MMSE) 
was performed for evaluation of mental and cognitive 
status. The Mini Mental State Examination (MMSE) is 
the most commonly used test for complaints 
of memory problems [16]. 
It is a sensitive, valid and reliable 30-point 
questionnaire that is used extensively in clinical and 
research settings to measure cognitive impairment. It 
is also used to estimate the severity and progression 
of cognitive impairment and to follow the course of 
cognitive changes in an individual over time; thus 
making it an effective way to document an individual's 
response to treatment. Administration of the test takes 
between 5–10 minutes and examines functions 
including registration, attention, calculation, recall, 
language, commands and orientation [17]. 
3 - Sleep and life style questionnaire.  A 
questionnaire designed to evaluate subjective sleep 
quality and number of sleeping hours and their pattern 
were evaluated. Evaluation of life style was achieved 
through questioning: Exposure to sun: time, duration 
and clothing. General subjective life stresses, mood, 
tea and coffee consumption, general activity and 
history of exercising, which were recorded and put on 
a 3 points scale. 
Classification and scoring system: Sleeping 
hours: 4-6 =1, 6-8 =2 and 8-10 = 3; MMSE: 22-26 =1, 
26-28=2 and 28- 29=3; Mood: bad = 1, regular =2 and 
good =3; Tea and coffee consumption (number of 
cups per day): 0-1 =1, 2-4 =2 and 5-8 =3. Exposure to 
sun, sleep quality, stress, general activity and 
exercising: 1 = low, 2 = medium, and 3 = high.  
After the first visit evaluation, the patients 
were classified into 3 groups according to their total 
sleeping hours, group (1) consists of 29 patients who 
slept (4-6) hours per night, group (2) consists of 60 
patients, they slept from (6-8) hours per night, and 
group (3) consists of 3 patients, who slept from (8-10) 
hours per night. Group (1) was instructed to make 
some changes in their life style in order to increase 
sleeping hours by 1-2 hours per night. 
4 - Anthropometric parameters and blood 
pressure measurements. Measurements of height and 
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body weight were taken to calculate body mass index 
(BMI), where BMI= weight in kg/square height in 
meters. Blood pressure for each patient was 
measured weekly. All measurements were taken by 
the same researcher to assure accuracy. 
5 - Dietary recall. Data on dietary intake 
before the intervention were performed using the 24 
hours dietary intake recall, aiming to correct eating 
habits. All food items and portions were recorded by 
the same researcher in details.  
 6 - Blood sampling and biochemical analysis. 
Fasting blood samples (8 hours fasting) were drawn 
from the patients. Fasting blood glucose (FBG) was 
determined on fresh samples; other biochemical 
parameters were performed on the fasting blood sera 
that were stored at -70°C until used. The FBG was 
determined by using glucose oxidase method [18]. C-
peptide was detected by C-peptide Enzyme 
Immunoassay Test Kit, catalogue No. E29-071, 
IMMUNOSPEC Corporation, Netherland, [19]. 
Modified homeostatic model assessment of insulin 
resistance (M. HOMA-IR) was calculated, where M. 
HOMA-IR = 1.5 + fasting blood glucose x fasting C-
peptide/2800 [20], in which insulin was replaced by C-
peptide so as to be applied on diabetic patients using 
exogenous insulin. Serum nicotinamide 
phosphoribosyltransferase (Visfatin) was measured by 
an enzyme-linked immunosorbent assay performed 
according to the directions of the supplier (EIAab® 
Immunoassay Kit, Catalog No: E0638h) [21].  
 
Study design and statistics  
This is an interventional study. Statistical 
analysis was performed using SPSS (17.0, 2008) 
software. Data are expressed as means ± SD and %. 
t–test for significance was used to compare the data. 
P -value was considered significant at < 0.05. 
 
 
Results 
 
As shown in Table 1, base line results 
regarding sleep duration was 31.7% of the 
participants (29 subjects) which represent group (1) 
had very low hours of sleep (4-6 total sleeping hours 
per night), and 65 % (60 subjects) which represent 
group (2) get moderate sufficient hours of sleep (6-8 
total sleeping hours per night), while 3.3% (3 subjects) 
represent group (3) get more than average hours of 
sleep (8-10 total sleeping hours per night). As for the 
mini mental state test which evaluate cognitive 
functions 10.7% of the participants have mild cognitive 
impairment, 80.5% have good mental functions and 
no signs of cognitive impairment, while 8.8% have 
excellent mental and cognitive functions. Sleep quality 
is low in 38.3% moderate in 36.9% and high in 24.8%. 
Criteria for sleep quality is subjective according to the 
patients recalling that they get up many times during 
night sleep and/or experiencing very shallow sleep 
that when they wake up they feel as if they were 
awake all night, also recalling feeling bad and 
exhausted, sometimes very sleepy, these are 
common comments from the patients suffering from 
low quality sleep. Exposure to sun is low in 48.5%, 
moderate in 31.3 % and high in 20.2%. Stress 
perception is recalled in 15.3 % as low, 49% as 
medium and 35.7% as high. General activity is low in 
23%, medium in 55% and high in 22%. Exercising is 
recorded low in 41.8%, medium in 50.1% and high in 
8.1 %. Bad mood is recorded in 26.4%, regular mood 
in 55.6 % and 18 % recorded good mood. The 
consumption of tea and coffee was low in 14.3 %, 
medium in 79.5 % and high in 6.2%. 
Table 1: Data presented as percentage of obese women at base 
line stage, and after 2 months of intervention according to their 
sleeping hours 
Variables Score (1) 
% (no.) 
Score (2) 
% (no.) 
Score (3) 
% (no.) 
Base 
line 
 
After 2 
months 
 
Base 
line 
 
After 2 
months 
 
Base 
line 
 
After 2 
months 
 
Sleeping hours 31.7(29) 20 (18) 65 (60) 77 (71) 3.3 (3) 3 (3) 
 
MMSE 
 
10.7 
 
4.3 
 
80.5 
 
86.7 
 
8.8 
 
9 
 
Sleep Quality 
 
38.3 
 
31.8 
 
36.9 
 
43.2 
 
24.8 
 
25 
 
Exposure to sun 
 
48.5 
 
47 
 
31.3 
 
33 
 
20.2 
 
20 
 
Stress 
 
15.3 
 
17 
 
49 
 
48 
 
35.7 
 
35 
 
General Activity 
 
23 
 
11.5 
 
55 
 
65.5 
 
22 
 
23 
 
Exercising 
 
41.8 
 
36.4 
 
50.1 
 
55.6 
 
8.1 
 
8 
 
Mood 
 
26.4 
 
18.6 
 
55.6 
 
62 
 
18 
 
19.4 
 
Tea and coffee 
consumption 
 
14.3 
 
24 
 
79.5 
 
71 
 
6.2 
 
5 
MMSE: Mini Mental State Examination; Sleeping hours: 4-6 = 1, 6-8 = 2, 8-10 = 3; MMSE:    
22-26 = 1, 26-28 = 2, 28- 29 = 3; Mood: bad = 1, regular = 2, good = 3; Tea and coffee 
consumption (number of cups per day): 0-1 = 1, 2-4 = 2, 5-8 = 3; Exposure to sun, sleep 
quality, stress, general activity and exercising: 1 = low, 2 = medium, 3 =high. 
 
All participants showed marked improvement 
in sleep duration and quality, cognitive functions, 
general activity, exercising and mood after 
intervention. A trend towards reducing tea and coffee 
consumption is seen as a result of the instructions the 
participants received to help improving sleep. 
Table 2 represents the data of the 3 groups 
classified according to sleep duration, where group (1) 
represents the least sleeping hours at base line (5.4 
hours per night). They showed the lowest scores in 
the MMSE indicating lower cognitive functions and 
highest mean BMI, the highest level of visfatin serum 
level, the highest value of M.HOMA-IR indicating more 
insulin resistance. After 2 months of intervention, 
significant improvement was seen in cognitive 
functions, BMI, visfatin serum level and insulin 
resistance (P< 0.05). The other 2 groups also showed 
improved cognitive functions, reduced BMI and 
visfatin serum level and insulin resistance but to a 
lesser extent when compared to group (1).  
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Table 2: Data of different groups before and after intervention classified according to their sleeping hours /night and expressed as 
mean ± SD 
Variables Group (1) (No.=29) Group (2) (No.=60) Group (3) (No.=3) 
Base line After 2 months  Base line After 2 months Base line After 2  months 
Sleeping hours 5.4 ± 0.71 6.5 ± 0.94
*
 7.45 ± 1.2 7.89 ± 1.1 8.8 ± 1.4 8.9 ± 1.37 
Visfatin (ng/ml) 34.8 ± 1.3 32.5 ± 1.7
*
 33.29 ± 1.9 31.2 ± 1.6
*
 33.19 ± 1.2 31.45 ± 1.1
*
 
M. HOMA-IR 1.72 ± 0.031 1.63 ± 0.024
*
 1.68 ± 0.047 1.60 ± 0.03
*
 1.69 ± 0.03 1.61 ± 0.029
*
 
  MMSE 24.2 ± 2.0 25.6 ± 1.9
*
 27.1 ± 0.05 27.9 ± 0.03 28.5 ± 0.03 29.0 ± 0.021 
  BMI (kg/m²) 37.23 ± 1.8 33.2 ± 1.7
*
 35.8 ± 2.9 31.95 ± 2.8
*
 36.1 ± 2.3 31.56 ± 2.1
*
 
M. HOMA-IR:  Modified Homeostatic Model Assessment of Insulin Resistance, MMSE: Mini Mental State Examination, BMI: Body Mass Index. 
*
P -value is considered significant at< 0.05. 
 
 
 
Table 3 shows significant reduction in BMI 
among all participants, accompanied by significant 
reduction in serum visfatin level, insulin resistance, 
fasting blood glucose and C-peptide. Our study shows 
elevated visfatin level among all groups at baseline. 
After the intervention significant reduction was 
recorded in the visfatin level but was still much higher 
than normal level. 
Table 3: Data for all participants expressed as mean ± SD at the 
base line and after 2 months of intervention 
Variables Base line After 2 months 
BMI (kg/m²) 36.14 ± 3.0 32.8 ± 2.7
*
 
FBG (mg/dl) 111.38 ± 4.0 98.45 ± 3.0
*
 
C-peptide (ng/ml) 4.67 ± 0.98 3.69 ± 0.86
*
 
M.HOMA-IR 1.69 ± 0.04 1.60 ± 0.03
*
 
Visfatin (ng/ml) 33.87 ± 2.8 31.76 ± 2.5
*
 
BMI: Body Mass Index, FBG: Fasting Blood Glucose, M. HOMA-IR: Modified Homeostatic 
Model Assessment of Insulin Resistance. 
*
P -value is considered significant at< 0.05. 
 
 
Discussion  
 
Most studies put 6 hours of sleep as a cut off 
point for sleep deficiency, which if not achieved, 
several negative consequences follow.  
In our study more than 30 % of the 
participants reported to sleep from 4-6 hours per day, 
group (1), which means that they are sleeping 
deficient. This group when compared to the other 
groups with more sleeping hours showed the highest 
BMI, lowest cognitive functions, highest levels of 
visfatin, and highest insulin resistance. After 2 months 
of intervention through following a balanced low 
caloric diet and increasing sleep duration in those 
sleep deficient, improvement was recorded in BMI, 
cognitive functions, insulin resistance and visfatin 
serum level, but the highest improvement level was 
recorded in group (1) as seen in Table 2. In our study, 
all participants are obese which puts the body in a 
low-grade inflammatory state, in group one with sleep 
deficiency, an additional risk factor is added, that is 
sleep deficiency. That’s why group (1) showed worse 
scores at base line and achieved the highest level of 
improvement after intervention. We suggest that sleep 
deficiency can be an additional risk factor for obesity, 
cognitive impairment, insulin resistance and low-grade 
inflammatory state.  
 
 
Sleep and obesity  
In agreement with the data detected in this 
study, accumulating evidence has pointed to an 
association between sleep inadequacy and obesity. In 
the last 50 years, self-reported sleep duration in the 
United States has decreased by 1.5–2 hours due to 
lifestyle changes. According to the latest surveys, 
36% of the adult population is obese and one third of 
adults report sleeping less than 6 hours per night, 
substantially less than the recommended 7–9 hours 
sleep per night [22]. Chronic sleep deprivation and 
obesity may be related in a bidirectional fashion, and 
they have similar consequences, including 
hypertension, diabetes, and cognitive impairment. 
Previous studies reported the gradual decline in the 
amount of time spent asleep and also the routine 
extension of normal activity during the night may 
disrupt synchrony between the periods of 
sleep/activity with alternating periods of 
feeding/fasting and energy storage/utilization. Indeed, 
the relationship between sleep restrictions, weight 
gain may involve at least in part alterations in glucose 
metabolism, stimulation of appetite, and decreased 
energy expenditure [23, 24]. 
Several epidemiological studies have shown 
that people who report sleeping less than 6.5 hours 
are at greater risk of gaining weight over time and 
reduced ability to lose weight. Sleep restriction 
increases food intake beyond the energetic costs of 
increased time spent awake due to disrupted appetite-
regulating hormones, altered brain mechanisms 
involved in the hedonic aspects of appetite, and/or 
changes in sleep quality and architecture [3, 25]. 
It was reported that acute sleep deprivation 
can induce insulin resistance. There are several 
postulated mechanisms for the effect of sleep 
curtailment on development of insulin resistance as 
well as for predisposition for Type 2 diabetes: 
increase of sympathetic neuronal activity, decreased 
cerebral utilization of glucose, increase in evening 
cortisol values, growth hormone increase and disorder 
of neuroendocrine control of appetite which increases 
the risk for getting the body weight [26]. 
A meta-analysis of 45 cross-sectional studies, 
including 604,509 adults and 30,002 children, 
confirmed the relationship between short sleep and 
obesity, most of the included studies used actigraphy 
or self-reported sleep duration, women, but not men, 
who slept fewer than five hours, had a higher risk of 
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gaining 5 kg in two years. Interestingly, in this study, 
BMI was also increased in women sleeping more than 
eight hours [27]. A study suggested the bidirectional 
effect of sleep-obesity suggesting that weight loss 
may improve sleep, and these improvements may 
promote further weight loss. Overall, improving sleep 
duration and quality is a potential tool to counteract 
the epidemics of obesity [3, 28]. 
 
Sleep and cognition  
In our study, group (1) with the least sleeping 
hours showed the least scores in the cognitive test 
evaluation linking sleep deficiency to cognitive 
impairment. Several studies support this link as they 
reported that obesity and sleep deprivation have been 
linked to cognitive deficits. Sleep deprivation 
decreases attention and impairs processing speed. 
Sleep quality was worst in participants with memory, 
attention and motor domains impairments. Memory 
function was correlated with sleep efficiency [29, 30]. 
Furthermore, sleep extension can improve declarative 
memory in adolescents. A study reported that 
extending sleep hours resulted in attention improved 
by 10%; memory and executive functions tended to 
improve by 7% and 5%, respectively [11]. A study 
reported that getting even 1 hour less than the 
required sleep (7 to 8 hours nightly) leads to problems 
with memory, concentration, and attention. A study 
reported that sleep extension in chronically sleep-
deprived obese individuals who exhibited 
neurocognitive deficits was partially reversible; self-
reported sleep quality, duration and sleepiness, all 
improved to a clinically meaningful extent as well. 
These improvements were achieved in a non-
pharmacological way in a real life situation and were 
sustained over a long time. In conclusion, the findings 
suggest that night-time sleep is important for cognitive 
function [11]. Also some studies searched the link 
between sleep and Alzheimer's disease (AD). Sleep is 
frequently impaired in individuals with AD. Sleep is 
probably one component of a variety of risk factors 
contributing to AD [31].  
 
Obesity and cognition 
Several previous studies reported that obese 
individuals exhibit deficits in memory, attention, 
executive functions, including mental flexibility, 
planning, problem solving, and display impulsivity. 
Insulin resistance in obese patients and the low-grade 
inflammatory status play an important role in cognitive 
impairment [32]. The link between obesity and 
dementia in women was stronger than that in men. 
Women who developed dementia had a higher 
average BMI compared to women without dementia 
[33], this matches our results. 
  
 
Sleep and insulin resistance 
In our study, insulin resistance was worst in 
sleep deficient group and showed the best 
improvement when sleeping hours were extended. 
Several cross-sectional studies showed that short 
sleep may now qualify as an additional clinical factor 
in the development of insulin resistance and diabetes. 
One possibility is sleep may impact secretion of 
adipocyte derived hormones that regulate 
inflammation and insulin resistance. As indicated by 
studies of sleep deprivation, the mechanisms 
connecting short sleep and obesity/insulin resistance 
are probably mediated by three pathways: increases 
in appetite, decreases in energy expenditure, and 
influences on glucose metabolism [3, 6, 34]. 
 
Sleep, obesity and inflammation 
In the present study, visfatin was found to be 
elevated in all patients as seen in Table 3 (33.87 ± 2.8 
ng/ml vs. 17.3 ng/ml which is the reference level), with 
its highest level in group (1) with sleep deficiency (5.4 
± 0.71 sleeping hours per night). This may be 
explained as sleep deficiency is an additional factor 
that increases the state of low-grade inflammation in 
the body, adding to the original inflammatory status 
due to obesity. That is why obese patients have 
elevated visfatin serum level, but the group with sleep 
deficiency showed even higher level of visfatin. 
Visfatin is a recently discovered adipokine 
produced and secreted primarily by visceral adipose 
tissue (VAT). Visfatin correlated positively with insulin 
and HOMA-IR in obese subjects [35]. Recent studies 
reported that the important role of Visfatin in the 
development of obesity, diabetes mellitus, and 
metabolic syndrome continues to rise. A study 
reported a significantly higher visfatin level in the 
obese subjects compared to the control group 
(median Visfatin level of 39.6 vs.17.3 ng/ml, p = 
0.0006) [36]. In a group of people with total sleep time 
(TST) of 6.2 hours, each hour reduction in TST was 
associated with 14% increase in visfatin levels. 
Another study reported an inverse association 
between sleep duration and levels of both leptin and 
visfatin. These findings suggest reduced sleep may 
have detrimental effects on adipose tissue function 
and these effects may help explain the systemic 
inflammation and insulin resistance associated with 
sleep deficiency [37-39].  
Low-grade systemic inflammation due 
to obesity is considered to be the key link 
between obesity and obesity-related disorders. Weight 
loss in combination with increased physical activity, a 
negative energy balance, and diet adjustment was 
associated with lower inflammation [38]. In addition, 
adipokines play important roles in the regulation of 
appetite and satiety, fat distribution, insulin sensitivity 
and insulin secretion, energy expenditure, 
inflammation, blood pressure, hemostasis, and 
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endothelial function [40, 41].  
In our study significant decrease in Visfatin 
level accompanied by improvement in cognitive 
functions was seen after the 2 months of following low 
caloric diet and increasing sleeping hours. We can 
interpret these changes to the weight loss and 
improved sleeping that reduced the inflammatory 
status of the body. An important study reported that 
the inflammatory status that is caused by obesity in 
itself can be a factor that makes behavioral 
symptoms, including depressive symptoms, cognitive 
impairment and sleep problems [42]. 
 In conclusion, we are shedding the light on a 
dangerous change in life style which is sleep 
inadequacy, where about one third of our sample slept 
around 5 hours per night. This study suggests that 
sleep deficiency is proposed as a modifiable risk 
factor for obesity and cognitive impairment mediated 
through insulin resistance and low–grade 
inflammatory status. Awareness and guidance are 
needed to improve life style including healthy diet and 
adequate sleep to help controlling obesity and 
cognitive impairment.  
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